Stock MOOD DOSEOLOGY SCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Doseology Sciences Inc.

Equities

MOOD

CA2584842033

Pharmaceuticals

Market Closed - Canadian Securities Exchange
Other stock markets
 08:49:43 09/05/2024 pm IST 		5-day change 1st Jan Change
0.48 CAD 0.00% Intraday chart for Doseology Sciences Inc. -7.69% +220.00%
2023 Doseology Sciences Inc. Announces CFO Changes CI
2023 Doseology Sciences Inc. Announces CEO Changes CI

Business Summary

Lucy Scientific Discovery Inc., formerly Doseology Sciences Inc., is an early-stage psychedelic manufacturing company. The Company is focused on research, development and manufacturing for the emerging psychedelic-based medicine industry. The Company is advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies, medicines, and commercial products. It is engaged in developing consumer product manufacturing, marketing and distribution. The Company is dedicated to the production of a variety of natural, synthetic and biosynthetic products to meet the needs of the psychotropics-based medicine market.

Sales per Business

CAD in Million2022Weight2023Weight Delta
Functional Mushroom Products
100.0 %
0 100.0 % 0 100.0 % +168.49%

Sales per region

CAD in Million2022Weight2023Weight Delta
Canada
97.0 %
0 100.0 % 0 97.0 % +160.44%
United States
3.0 %
-- 0 3.0 % -

Managers

Managers TitleAgeSince
Daniel Vice FOU
 Founder 35 10/19/10
Shawn Balaghi CEO
 Chief Executive Officer 55 05/23/05
Basin CTO
 Chief Tech/Sci/R&D Officer - -
Scott Reeves BRD
 Director/Board Member 55 27/20/27
Lindsay Hamelin SEC
 Corporate Secretary 37 05/23/05

Members of the board

Members of the board TitleAgeSince
Scott Reeves BRD
 Director/Board Member 55 27/20/27
Shawn Balaghi CEO
 Chief Executive Officer 55 05/23/05
Daniel Vice FOU
 Founder 35 10/19/10

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 4,400,515 4,227,515 ( 96.07 %) 0 96.07 %

Shareholders

NameEquities%Valuation
Scott Reeves
1.875 %
82,500 1.875 % 25 905 $
Daniel Vice
1.852 %
81,500 1.852 % 25 591 $
David Lutz
0.1136 %
5,000 0.1136 % 1 570 $
Shawn Balaghi
0.0909 %
4,000 0.0909 % 1 256 $
Pratik Patel
0.000000 %
0 0.000000 % - $

Company contact information

Doseology Sciences, Inc.

9-3151 Lakeshore Road Unit 305

V1W 3S9, Kelowna

+236 349 0064

http://www.doseology.com
address Doseology Sciences Inc.(MOOD)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
DOSEOLOGY SCIENCES INC. Stock Doseology Sciences Inc.
+220.00% 15.53L
NOVO NORDISK A/S Stock Novo Nordisk A/S
+30.53% 60TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-2.60% 37TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.83% 33TCr
ABBVIE INC. Stock AbbVie Inc.
+5.69% 29TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.34% 24TCr
NOVARTIS AG Stock Novartis AG
+9.54% 21TCr
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 20TCr
AMGEN INC. Stock Amgen Inc.
+10.77% 17TCr
PFIZER, INC. Stock Pfizer, Inc.
+0.10% 16TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. MOOD Stock
  4. Company Doseology Sciences Inc.
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.**#000000**/services/solutions/**#fff826**#ff3000**#ffffff**BENEFIT NOW**0**linear-gradient(180deg, rgba(42,73,76,1) 0%, rgba(28,30,51,1) 53%);**linear-gradient(180deg, rgba(255, 248, 38,1) 0%, rgba(247, 239,1) 53%);**date_fin_hors_prolongation**49**on all our subscriptions**
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW